Baxter (BAX) Misses Q2 EPS by 7c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts BAX Hot Sheet
Price: $26.00 --0%
Revenue Growth %: +2.5%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +2.5%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Baxter (NYSE: BAX) reported Q2 EPS of $0.64, $0.07 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.87 billion.
GUIDANCE:
Baxter sees FY2020 EPS of $3.00-$3.10, versus the consensus of $3.30.
For earnings history and earnings-related data on Baxter (BAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- GE Vernova T&D India (GVTD:IN) PT Raised to INR5,300 at Emkay Global
- Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
